ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2745

Plasma of Patients with Active Behçet´s Disease (BD) Increases Neutrophil Extracellular Trap Formation, Oxidative Metabolism and NADPH-Oxidase Expression in Normal and BD Neutrophils, and Carries Several Neutrophil Stimulating Factors

Sandro F. Perazzio1,2, Paulo Vitor Soeiro Pereira3, Alexandre W. S. de Souza1, Antonio Condino-Neto3 and Luis Eduardo C. Andrade2,4, 1Rheumatology, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 2Fleury Medicine and Health, Sao Paulo, Brazil, 3Immunology, ICB IV - Universidade de São Paulo, São Paulo, Brazil, 4Fleury Laboratories, Sao Paulo, Brazil

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome, Neutrophil Extracellular Traps and innate immunity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Plasma factors seem to play a role in Behçet’s disease (BD) pathogenesis, especially by increasing phagocyte oxidative profile. No data exists regarding neutrophil extracellular trap (NET) formation. We investigate the effect of plasma from patients with active BD (aBD) and inactive BD (iBD) on NET formation and oxidative burst, and searched for candidate soluble factors.

Methods

Neutrophils, peripheral blood mononuclear cells (PBMC) and plasma were obtained from patients with aBD (n=30), iBD (n=31), and healthy controls (HC; n=30). H2O2 and O2– production was determined by luminol/lucigenin luminescence with or without stimulation with phorbol myristate acetate (PMA), Streptococcus pneumoniae, Streptococcus sanguinis, Candida albicans or human plasma (from HC, iBD or aBD). Gene expression for the five NADPH-oxidase subunits was determined by qRT-PCR in resting cells, and protein expression by flow cytometry before and after stimulation with PMA or human plasma. NET formation was quantified after stimulus with PMA or human plasma, followed by labeling with anti-histones antibody, anti-neutrophil elastase antibody and Sytox Orange.

Results

Neutrophil production of O2–/H2O2 (Table 1) and NADPH-oxidase expression (Table 2) was higher after stimulus with aBD or iBD plasma than with HC plasma. PBMC displayed equivalent results. Resting and pathogen-stimulated phagocytes presented equivalent O2–/H2O2 production and NADPH-oxidase expression. NET formation was constitutively increased in aBD and iBD, compared to HC neutrophils (Table 3). Similarly, neutrophils from aBD and iBD produced more extensive NET than neutrophils from HC when stimulated with iBD plasma. In neutrophils from each group, aBD plasma induced greater NET formation than iBD or HC plasma. Eighteen soluble factors had increased concentration in aBD or BD plasma, and six were increased in both (Table 3). There was no significant difference in medication use between aBD and iBD patients.

Conclusion

Plasma from patients with aBD exerts a strong stimulus on NET formation and phagocyte oxidative burst. Increased concentration of MIP-1β, TNFα and other soluble plasma factors might be associated with neutrophil hyperactivity in BD. These findings warrant further studies in order to identify possible metabolic pathways involved in neutrophil activation in BD.


Disclosure:

S. F. Perazzio,
None;

P. V. S. Pereira,
None;

A. W. S. de Souza,
None;

A. Condino-Neto,
None;

L. E. C. Andrade,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/plasma-of-patients-with-active-behcets-disease-bd-increases-neutrophil-extracellular-trap-formation-oxidative-metabolism-and-nadph-oxidase-expression-in-normal-and-bd-neutrophils-and-carries/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology